Cargando…

Subjective outcomes 12 years after transvaginal mesh versus native tissue repair in women with recurrent pelvic organ prolapse; a randomized controlled trial

INTRODUCTION AND HYPOTHESIS: The present study describes an extended follow-up study after 12 years and focusses on subjective outcomes of women who underwent surgery for recurrent pelvic organ prolapse in the randomized index study. METHODS: One hundred and ninety-four (194) women had been randomiz...

Descripción completa

Detalles Bibliográficos
Autores principales: Kluivers, Kirsten B., Kamping, Metteke, Milani, Alfredo L., IntHout, Joanna, Withagen, Mariella I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10287778/
https://www.ncbi.nlm.nih.gov/pubmed/36662272
http://dx.doi.org/10.1007/s00192-022-05442-9
_version_ 1785061947039809536
author Kluivers, Kirsten B.
Kamping, Metteke
Milani, Alfredo L.
IntHout, Joanna
Withagen, Mariella I.
author_facet Kluivers, Kirsten B.
Kamping, Metteke
Milani, Alfredo L.
IntHout, Joanna
Withagen, Mariella I.
author_sort Kluivers, Kirsten B.
collection PubMed
description INTRODUCTION AND HYPOTHESIS: The present study describes an extended follow-up study after 12 years and focusses on subjective outcomes of women who underwent surgery for recurrent pelvic organ prolapse in the randomized index study. METHODS: One hundred and ninety-four (194) women had been randomized in the original study and in the present study, 45 (47%) in the vaginal mesh repair versus 43 (43%) women with conventional vaginal native tissue repair completed the long-term questionnaires. The mesh used was a first-generation non-absorbable mesh kit. All types of conventional vaginal native tissue repairs were allowed, and additional vaginal native tissue repairs were allowed in the mesh group. The questionnaires as applied at baseline were used. The Patient Global Impression of Improvement questionnaire (PGI-I) was the primary outcome. RESULTS: At 12 years, 30 (71%) women in the mesh group versus 23 (59%) women in the native tissue repair group reported to be PGI-I (very) much improved (p=0.24). There were no differences found in any of the questionnaire domains. There was, however, a higher number of women who had had additional operations for recurrent pelvic organ prolapse, stress urinary incontinence, and/or exposure in the mesh group: 18 women (40%) in the mesh group versus 8 women (19%) in the native tissue repair group (p=0.03). CONCLUSIONS: There was no difference in subjective outcome between the groups, but there was a statistically significant higher number of women who had needed further operations. This study confirms that vaginal mesh should not be used in all women with recurrent pelvic organ prolapse.
format Online
Article
Text
id pubmed-10287778
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-102877782023-06-24 Subjective outcomes 12 years after transvaginal mesh versus native tissue repair in women with recurrent pelvic organ prolapse; a randomized controlled trial Kluivers, Kirsten B. Kamping, Metteke Milani, Alfredo L. IntHout, Joanna Withagen, Mariella I. Int Urogynecol J Original Article INTRODUCTION AND HYPOTHESIS: The present study describes an extended follow-up study after 12 years and focusses on subjective outcomes of women who underwent surgery for recurrent pelvic organ prolapse in the randomized index study. METHODS: One hundred and ninety-four (194) women had been randomized in the original study and in the present study, 45 (47%) in the vaginal mesh repair versus 43 (43%) women with conventional vaginal native tissue repair completed the long-term questionnaires. The mesh used was a first-generation non-absorbable mesh kit. All types of conventional vaginal native tissue repairs were allowed, and additional vaginal native tissue repairs were allowed in the mesh group. The questionnaires as applied at baseline were used. The Patient Global Impression of Improvement questionnaire (PGI-I) was the primary outcome. RESULTS: At 12 years, 30 (71%) women in the mesh group versus 23 (59%) women in the native tissue repair group reported to be PGI-I (very) much improved (p=0.24). There were no differences found in any of the questionnaire domains. There was, however, a higher number of women who had had additional operations for recurrent pelvic organ prolapse, stress urinary incontinence, and/or exposure in the mesh group: 18 women (40%) in the mesh group versus 8 women (19%) in the native tissue repair group (p=0.03). CONCLUSIONS: There was no difference in subjective outcome between the groups, but there was a statistically significant higher number of women who had needed further operations. This study confirms that vaginal mesh should not be used in all women with recurrent pelvic organ prolapse. Springer International Publishing 2023-01-20 2023 /pmc/articles/PMC10287778/ /pubmed/36662272 http://dx.doi.org/10.1007/s00192-022-05442-9 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Kluivers, Kirsten B.
Kamping, Metteke
Milani, Alfredo L.
IntHout, Joanna
Withagen, Mariella I.
Subjective outcomes 12 years after transvaginal mesh versus native tissue repair in women with recurrent pelvic organ prolapse; a randomized controlled trial
title Subjective outcomes 12 years after transvaginal mesh versus native tissue repair in women with recurrent pelvic organ prolapse; a randomized controlled trial
title_full Subjective outcomes 12 years after transvaginal mesh versus native tissue repair in women with recurrent pelvic organ prolapse; a randomized controlled trial
title_fullStr Subjective outcomes 12 years after transvaginal mesh versus native tissue repair in women with recurrent pelvic organ prolapse; a randomized controlled trial
title_full_unstemmed Subjective outcomes 12 years after transvaginal mesh versus native tissue repair in women with recurrent pelvic organ prolapse; a randomized controlled trial
title_short Subjective outcomes 12 years after transvaginal mesh versus native tissue repair in women with recurrent pelvic organ prolapse; a randomized controlled trial
title_sort subjective outcomes 12 years after transvaginal mesh versus native tissue repair in women with recurrent pelvic organ prolapse; a randomized controlled trial
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10287778/
https://www.ncbi.nlm.nih.gov/pubmed/36662272
http://dx.doi.org/10.1007/s00192-022-05442-9
work_keys_str_mv AT kluiverskirstenb subjectiveoutcomes12yearsaftertransvaginalmeshversusnativetissuerepairinwomenwithrecurrentpelvicorganprolapsearandomizedcontrolledtrial
AT kampingmetteke subjectiveoutcomes12yearsaftertransvaginalmeshversusnativetissuerepairinwomenwithrecurrentpelvicorganprolapsearandomizedcontrolledtrial
AT milanialfredol subjectiveoutcomes12yearsaftertransvaginalmeshversusnativetissuerepairinwomenwithrecurrentpelvicorganprolapsearandomizedcontrolledtrial
AT inthoutjoanna subjectiveoutcomes12yearsaftertransvaginalmeshversusnativetissuerepairinwomenwithrecurrentpelvicorganprolapsearandomizedcontrolledtrial
AT withagenmariellai subjectiveoutcomes12yearsaftertransvaginalmeshversusnativetissuerepairinwomenwithrecurrentpelvicorganprolapsearandomizedcontrolledtrial